Citigroup’s ProShares Ultra Health Care RXL Stock Holding History
Bought
Maintained
Sold
Other funds holding RXL
TFA
CIAS
BCWM
CAS
Citigroup's RXL Position: Q4 2024 in Review
Citigroup sold out of ProShares Ultra Health Care (RXL) in Q4 2024, closing a stake of 320 shares — an estimated $17.9K sold.
Citigroup first reported a position in RXL in Q3 2013 and held it in 30 quarters. The position peaked at $48K in Q4 2019. 16 funds tracked by Wall St. Rank hold RXL as of Q4 2024.
- Citigroup reported no remaining ProShares Ultra Health Care position as of Q4 2024 after selling out during the quarter.
- Citigroup sold 320 ProShares Ultra Health Care shares in Q4 2024, an estimated $17.9K.
- Citigroup first reported a position in ProShares Ultra Health Care in Q3 2013 and held it in 30 quarters.
- Citigroup's ProShares Ultra Health Care position peaked at $48K in Q4 2019.
- 16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2024.
Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.